Really? No way!


The title says it all tonight for me. I just should not be surprised anymore and yet I still try thinking positive about you wolfie. You are starting to tick me off good and proper. I will win this round so watch out!

I will be seeing and/or talking to two of my docs tomorrow. The reason? Wolfie is acting up in a different way. For the last couple of days, I have felt pain in my right side up around the bottom of the shoulder blade. The pain radiates from back to front, in other words, I am hurting all the way through. It is maddening. I mean, come one now, give me a break here… this stupid flare is going on strong with no end in sight. Now this happens!

To the best of my knowledge, there are several possibilities on what it could be. One, pleurisy (not fun and hurts really bad). Two, kidney infection (which depending on how the kidney is involved may mean chemo again). Three, costochondritis, a nasty condition that is quite painful. None of it is good.

So, I will try to get on here and post what I find out tomorrow. In the meantime, I am trying to rest and keep my mind off the pain. Yeah, well, it hurts but this will pass once we know what it is.

Lupus Nephritis


This information is from the following webpage: and discusses the basics of kidney involvement and lupus. It is informational and just shows the basics. If you have questions, please discuss them with your doctor.


What is lupus nephritis?

Lupus nephritis is an inflammation of the kidney caused by systemic lupus erythematosus (SLE), a disease of the immune system. SLE typically causes harm to the skin, joints, kidneys, and brain.

The causes of SLE are unknown. Many factors may play a role, including

  • gender—SLE is more common in women than men
  • heredity—a gene passed down by a parent
  • infections
  • viruses
  • environmental causes

What are the symptoms of lupus nephritis?

Lupus nephritis may cause weight gain, high blood pressure, dark urine, or swelling around the eyes, legs, ankles, or fingers. However, some people with SLE have no overt symptoms of kidney disease, which must be diagnosed by blood and urine tests.

How is lupus nephritis diagnosed?

Diagnosis may require urine and blood tests as well as a kidney biopsy.

  • Urine test: Blood or protein in the urine is a sign of kidney damage.
  • Blood test: The kidneys remove waste materials like creatinine and urea from the blood. If the blood contains high levels of these substances, kidney function is declining. Your doctor should estimate your glomerular filtration rate based on your creatinine score.
  • Kidney biopsy: A biopsy is a procedure to obtain a tissue sample for examination with a microscope. To obtain a sample of your kidney tissue, your doctor will insert a long needle through the skin. Examining the tissue with a microscope can confirm the diagnosis of lupus nephritis and help to determine how far the disease has progressed.


How is lupus nephritis treated?

Treatment depends on the symptoms and test results. Medicines called corticosteroids can decrease swelling and inflammation by suppressing the immune system. Additional immunosuppressive drugs related to cancer and drugs used to prevent rejection of organ transplants may also be used. In severe cases, your doctor may prescribe cyclophosphamide (Cytoxan, Neosar) or mycophenolate (CellCept). Newer experimental treatments include a drug called rituximab (Rituxan).

You may need one or more medicines to control your blood pressure.

You may need to limit protein, sodium, and potassium in your diet.

The U.S. Government does not endorse or favor any specific commercial product or company. Trade, proprietary, or company names appearing in this document are used only because they are considered necessary in the context of the information provided. If a product is not mentioned, the omission does not mean or imply that the product is unsatisfactory.

For More Information

Lupus nephritis is also classified as a glomerular disease. For more information, see the National Kidney and Urologic Diseases Information Clearinghouse publication Glomerular Diseases.

The National Institute of Arthritis and Musculoskeletal and Skin Diseases has online publications about Systemic Lupus Erythematosus and The Many Shades of Lupus (easy-to-read).

More information is also available from

National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institutes of Health
1 AMS Circle
Bethesda, MD 20892–3675
Phone: 1–877–22–NIAMS (226–4267) or 301–495–4484

Lupus Foundation of America, Inc.
2000 L Street NW, Suite 710
Washington, DC 20036
Phone: 1–800–558–0121 or 202–349–1155

You may also find additional information about this topic by visiting MedlinePlus at

This publication may contain information about medications. When prepared, this publication included the most current information available. For updates or for questions about any medications, contact the U.S. Food and Drug Administration toll-free at 1–888–INFO–FDA (1–888–463–6332) or visit Consult your doctor for more information.


National Kidney and Urologic Diseases Information Clearinghouse

3 Information Way
Bethesda, MD 20892–3580
Phone: 1–800–891–5390
TTY: 1–866–569–1162
Fax: 703–738–4929

The National Kidney and Urologic Diseases Information Clearinghouse (NKUDIC) is a service of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The NIDDK is part of the National Institutes of Health of the U.S. Department of Health and Human Services. Established in 1987, the Clearinghouse provides information about diseases of the kidneys and urologic system to people with kidney and urologic disorders and to their families, health care professionals, and the public. The NKUDIC answers inquiries, develops and distributes publications, and works closely with professional and patient organizations and Government agencies to coordinate resources about kidney and urologic diseases.

Publications produced by the Clearinghouse are carefully reviewed by both NIDDK scientists and outside experts.

This publication is not copyrighted. The Clearinghouse encourages users of this publication to duplicate and distribute as many copies as desired.